Ameritas Investment Partners, Inc. Oncocyte Corp Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.86 - $1.53 $4,554 - $8,102	-5,296 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$1.38 - $2.63 $4,692 - $8,942	3,400 Added 179.32%	5,296 $13,000
Q2 2019 Aug 14, 2019	BUY	$2.49 - $5.45 $4,721 - $10,333	1,896 New	1,896 $5,000
Q2 2018 Aug 13, 2018	SELL	$2.0 - $3.3 $632 - $1,042	-316 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	316	316 $2,000

1.16M

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $351M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.